Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-24T06:12:24.663Z Has data issue: false hasContentIssue false

Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease

Published online by Cambridge University Press:  08 March 2006

S De
Affiliation:
Department of Otorhinolaryngology, University of Liverpool, UK
J E Fenton
Affiliation:
Department of Otorhinolaryngology, University of Liverpool, UK
A S Jones
Affiliation:
Department of Otorhinolaryngology, University of Liverpool, UK

Abstract

Matrix metalloproteinases (MMPs) are a family of zinc and calcium-dependent endopeptidases that play a key role in extracellular matrix (ECM) degradation. MMPs are known to be important in normal remodelling processes. Overexpression and activation of MMPs or an imbalance of active MMPs and tissue inhibitors of metalloproteinases (TIMPs) has been linked with a number of specific disease states associated with the breakdown and remodelling of the extracellular matrix. MMPs and TIMPs play a role in the development and progression of conditions such as acute and chronic otitis media, nasal polyposis and Sjogren’s disease of salivary glands. Their role in allergic rhinitis has not been proven although they do appear to have a role in asthma, a condition closely linked to rhinitis. The use of a broad spectrum MMP inhibitor has been shown to alter the outcome of acute otitis media and otitis media with effusion. Therapeutic strategies with anti-MMP molecules are currently being developed and may play a role in modulating the course of non-neoplastic otorhinolaryngological disease in the future.

Type
Research Article
Copyright
© 2005 Royal Society of Medicine Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)